Medicinal treatment of dermal diseases in dogs
AssigneeBridge Pharma, Inc.
InventorsA. K. Gunnar Aberg, Vincent B. Ciofalo
Life of this patent
Estimating the term…
Abstract
The methods disclosed herein relate to the treatment of dermal disorders, such as for example atopic dermatitis, in dogs, by administering a therapeutically effective amount of racemic norketotifen. Co-administrations with steroids or immunosuppressant drugs are described.
Claims16
A method for treating pruritic and/or inflammatory dermal disorders in a dog in need of such treatment, comprising orally administering to the dog in need a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof, wherein the therapeutically effective amount does not produce sedative side effects upon administration to the dog.
A method for reducing sedative side effects in the treatment of pruritic and/or inflammatory dermal disorders in a dog in need of such treatment, comprising orally administering to the dog in need a therapeutically effective amount of RS-norketotifen or a pharmaceutically acceptable salt thereof that does not produce sedative side effects upon administration to the dog.
Dependencies are inferred from the claim text.